Scott Engel
Plastic and Reconstructive Surgery · Sarasota, FLNPI 1104020056
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,640 of the $4,291 with a category attached, or 84.8%. AbbVie accounts for 63.9% of it on its own, with 8 other manufacturers making up the rest.
Across 177 payments — averaging $24.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Integra Lifesciences Corporation$678
- Motiva USA, LLC$413
- Merz North America, Inc.$259
- Mentor Worldwide LLC$108
- Galderma Laboratories, L.p.$45
- plus $47 from 3 others
Across 7 payments — averaging $5745.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Tepha Inc$40K
What the payments were for
- Food & beverage$3,64085%
- Other$65215%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 158 | $2,742 |
| Integra Lifesciences Corporation | 2 | $678 |
| Motiva USA, LLC | 7 | $413 |
| Merz North America, Inc. | 3 | $259 |
| Mentor Worldwide LLC | 1 | $108 |
| Galderma Laboratories, L.p. | 3 | $45 |
| Coopersurgical, Inc. | 1 | $21 |
| Innovation Technologies Inc | 1 | $14 |
| Sientra, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,291 in reported general payments places this provider in the 55th percentile of 235 plastic and reconstructive surgery providers in Florida.
See all plastic and reconstructive surgery providers in Florida →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aprepitant | 19 | $751 |
| Montelukast Sodium | 15 | $151 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 17 | $128 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 14 | $118 |
| Ondansetron OdtOndansetron | 24 | $92 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Sarasota
- James KotickSarasota$11K
- Brandon LambirisSarasota$10K
- Alan DurkinVero Beach$548K
- Edgar SosaVero Beach$504K
- Vaishali DoolabhJacksonville$306K
- Sai Ramakrishna Velamuri VenkataTampa$303K
- Lee GibsteinBay Harbor Islands$216K
- John MurrayJacksonville$188K
- Arthur DesrosiersMiami$156K
- Miguel MedinaMiami$80K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.